Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()

• Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor.

Detalles Bibliográficos
Autores principales: Christie, Alan, McKay, Neil, Nussey, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862295/
https://www.ncbi.nlm.nih.gov/pubmed/24371708
http://dx.doi.org/10.1016/j.gynor.2013.07.002
_version_ 1782295730626494464
author Christie, Alan
McKay, Neil
Nussey, Fiona
author_facet Christie, Alan
McKay, Neil
Nussey, Fiona
author_sort Christie, Alan
collection PubMed
description • Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor.
format Online
Article
Text
id pubmed-3862295
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-38622952013-12-26 Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery() Christie, Alan McKay, Neil Nussey, Fiona Gynecol Oncol Case Rep Case Report • Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor. Elsevier 2013-07-16 /pmc/articles/PMC3862295/ /pubmed/24371708 http://dx.doi.org/10.1016/j.gynor.2013.07.002 Text en © 2013 The Authors http://creativecommons.org/licenses/by-nc-sa/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike License, which permits non-commercial use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Case Report
Christie, Alan
McKay, Neil
Nussey, Fiona
Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
title Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
title_full Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
title_fullStr Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
title_full_unstemmed Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
title_short Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
title_sort dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862295/
https://www.ncbi.nlm.nih.gov/pubmed/24371708
http://dx.doi.org/10.1016/j.gynor.2013.07.002
work_keys_str_mv AT christiealan dermatomyositisaspresentingfeatureofovariancancertreatedwithneoadjuvantchemotherapyandintervaldebulkingsurgery
AT mckayneil dermatomyositisaspresentingfeatureofovariancancertreatedwithneoadjuvantchemotherapyandintervaldebulkingsurgery
AT nusseyfiona dermatomyositisaspresentingfeatureofovariancancertreatedwithneoadjuvantchemotherapyandintervaldebulkingsurgery

Ejemplares similares